Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
3 About The Trial Trial Name: A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities (SURMOUNT-5) ClinicalTrials.gov ID: NCT05822830 Sponsor: Eli Lilly and Company Completion Date: December 11, 2024 Investigators included 750 patients between April 21, 2023, and November 13, 2024, with 85% of patients completing treatment and 80.2% completing the 72 weeks of trial
SeekPeptides consistently emphasizes the importance of professional guidance alongside evidence-based peptide education
These components are selected based on individual goals and clinical history
S2CID 24024090
Ghasemi M, Malek M, Javanmard SH, Ghasemi A, Esfahani HN, Vaseghi G
US$ 25.68
US$ 28.60
US$ 20.38
